The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...

DUBLIN--(BUSINESS WIRE)--The "Ophthalmic Disease Therapeutics Market (2024 Edition): Analysis By Indication (Age-related macular degeneration, Diabetic macular edema, Other retinal disorders), By ...

One study found that marijuana use was associated with short-term relief from pain in patients who were resistant to other treatment options. Cannabis treatment ... help to prevent peripheral ...

The following content is for informational purposes only. This article is not intended to be a substitute for profession ...

USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 17, 2025 /PRNewswire/ -- According to experts, soon the integration of artificial intelligence ...

From a 14-year-old innovator in Frisco to an up-and-coming healthcare C-Suiter, these five up-and-comers are driving change ...

Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. During a presentation at ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...